Research Article

Interaction of Cholinergic and Cannabinoidergic Systems in Hemorrhagic Hypotension

Volume: 52 February 20, 2026
EN TR

Interaction of Cholinergic and Cannabinoidergic Systems in Hemorrhagic Hypotension

Abstract

Given the cardiovascular effects of the cholinergic and cannabinoid systems, the present study aimed to investigate the interaction of both systems in hemorrhagic hypotensive conditions. Adult male Sprague Dawley albino rats were used in the study. Under sevoflurane anesthesia, the animals were catheterized in the left carotid arteries and jugular vein for monitoring cardiovascular parameters and producing hemorrhagic hypotension and intravenous (IV) injection, respectively. The hypotension was achieved by withdrawing a total volume of 2.2 mL blood/100g body weight over 10 minutes. The hemorrhage produced a severe and long-lasting decrease in mean arterial pressure (MAP). The IV injection of rimonabant (cannabinoid CB1 receptor antagonist) and DMSO promptly and significantly increased the MAP in the hypotensive rats. When administered at a sub-effective dose CDP-choline showed a slight increase in the MAP. However, when this same dose of CDP-choline was co-administered with DMSO, it elicited a more pronounced and prolonged increase in the MAP compared to the effects observed with CDP-choline or DMSO alone. Rimonabant partially inhibited the MAP-increasing effect of the sub-effective dose of CDP-choline administered with DMSO in the hypotensive rats. These findings suggest that CDP-choline demonstrates a synergistic interaction with DMSO, resulting in a heightened and prolonged increase in MAP during hemorrhagic hypotension. Conversely, it exhibits an antagonistic interaction with rimonabant in terms of their effects on MAP under similar conditions. These results can be interpreted as indicative of an interaction between cannabinoid CB1 receptors and the cholinergic system in the hemorrhagic hypotensive condition.

Keywords

Supporting Institution

Bursa Uludag University Scientific Research Projects Commission Unit

Project Number

OUAP(T)-2017/2

Ethical Statement

Bursa Uludag University Local Animal Ethics Committee on 18.04.2017 (2017-07/02).

References

  1. 1.Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage ontrauma outcome: an overview of epidemiology, clinicalpresentations, and therapeutic considerations. J Trauma.2006;60:3-11.
  2. 2.Kauvar DS, Wade CE. The epidemiology and modernmanagement of traumatic hemorrhage: US and internationalperspectives. Crit Care. 2005;9:1-9.
  3. 3.Cairns CB. Rude unhinging of the machinery of life: metabolicapproaches to hemorrhagic shock. Curr Opin Crit Care.2001;7:437-443.
  4. 4.Peitzman AB, Billiar TR, Harbrecht BG, et al. Hemorrhagicshock. Curr Probl Surg. 1995;32:925-1002.
  5. 5.Jarrar D, Chaudry IH, Wang P. Organ dysfunction followinghemorrhage and sepsis mechanisms and therapeuticapproaches. Int J Mol Med. 1999;4:575-583.
  6. 6.Rossaint R, Cerny V, Coats TJ, et al. Key issues in advancedbleeding care in trauma. Shock. 2006;26:322-331.
  7. 7.Weiss GB. Metabolism and actions of CDP-choline as anendogenous compound and administered exogenously asciticoline. Life Sci. 1995;56:637-660.
  8. 8.Amenta F, Parnetti L, Gallai V, Wallin A. Treatment ofcognitive dysfunction associated with Alzheimer's disease withcholinergic precursors. Ineffective treatments or inappropriateapproaches? Mech Ageing Dev. 2001;122:2025-2040.

Details

Primary Language

English

Subjects

Neurosciences (Other)

Journal Section

Research Article

Publication Date

February 20, 2026

Submission Date

October 20, 2025

Acceptance Date

February 8, 2026

Published in Issue

Year 2026 Volume: 52

APA
Yanar, Y. B., Altınbaş, B., Çavun, S., Yalçın, M., & Yılmaz, M. S. (2026). Interaction of Cholinergic and Cannabinoidergic Systems in Hemorrhagic Hypotension. Journal of Uludağ University Medical Faculty, 52, 1807161. https://doi.org/10.32708/uutfd.1807161
AMA
1.Yanar YB, Altınbaş B, Çavun S, Yalçın M, Yılmaz MS. Interaction of Cholinergic and Cannabinoidergic Systems in Hemorrhagic Hypotension. Journal of Uludağ University Medical Faculty. 2026;52:1807161. doi:10.32708/uutfd.1807161
Chicago
Yanar, Yusuf Berkcan, Burçin Altınbaş, Sinan Çavun, Murat Yalçın, and Mustafa Sertaç Yılmaz. 2026. “Interaction of Cholinergic and Cannabinoidergic Systems in Hemorrhagic Hypotension”. Journal of Uludağ University Medical Faculty 52 (February): 1807161. https://doi.org/10.32708/uutfd.1807161.
EndNote
Yanar YB, Altınbaş B, Çavun S, Yalçın M, Yılmaz MS (February 1, 2026) Interaction of Cholinergic and Cannabinoidergic Systems in Hemorrhagic Hypotension. Journal of Uludağ University Medical Faculty 52 1807161.
IEEE
[1]Y. B. Yanar, B. Altınbaş, S. Çavun, M. Yalçın, and M. S. Yılmaz, “Interaction of Cholinergic and Cannabinoidergic Systems in Hemorrhagic Hypotension”, Journal of Uludağ University Medical Faculty, vol. 52, p. 1807161, Feb. 2026, doi: 10.32708/uutfd.1807161.
ISNAD
Yanar, Yusuf Berkcan - Altınbaş, Burçin - Çavun, Sinan - Yalçın, Murat - Yılmaz, Mustafa Sertaç. “Interaction of Cholinergic and Cannabinoidergic Systems in Hemorrhagic Hypotension”. Journal of Uludağ University Medical Faculty 52 (February 1, 2026): 1807161. https://doi.org/10.32708/uutfd.1807161.
JAMA
1.Yanar YB, Altınbaş B, Çavun S, Yalçın M, Yılmaz MS. Interaction of Cholinergic and Cannabinoidergic Systems in Hemorrhagic Hypotension. Journal of Uludağ University Medical Faculty. 2026;52:1807161.
MLA
Yanar, Yusuf Berkcan, et al. “Interaction of Cholinergic and Cannabinoidergic Systems in Hemorrhagic Hypotension”. Journal of Uludağ University Medical Faculty, vol. 52, Feb. 2026, p. 1807161, doi:10.32708/uutfd.1807161.
Vancouver
1.Yusuf Berkcan Yanar, Burçin Altınbaş, Sinan Çavun, Murat Yalçın, Mustafa Sertaç Yılmaz. Interaction of Cholinergic and Cannabinoidergic Systems in Hemorrhagic Hypotension. Journal of Uludağ University Medical Faculty. 2026 Feb. 1;52:1807161. doi:10.32708/uutfd.1807161

ISSN: 1300-414X, e-ISSN: 2645-9027

Creative Commons License
Journal of Uludag University Medical Faculty is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
2023